239 related articles for article (PubMed ID: 15138244)
1. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke.
Cipollone F; Toniato E; Martinotti S; Fazia M; Iezzi A; Cuccurullo C; Pini B; Ursi S; Vitullo G; Averna M; Arca M; Montali A; Campagna F; Ucchino S; Spigonardo F; Taddei S; Virdis A; Ciabattoni G; Notarbartolo A; Cuccurullo F; Mezzetti A;
JAMA; 2004 May; 291(18):2221-8. PubMed ID: 15138244
[TBL] [Abstract][Full Text] [Related]
2. [Study on the association of cyclooxygenase-2 -765g>C and prostacyclin synthase C1117A polymorphisms and the risk of myocardial infarction in Uigur population of Xinjiang, China].
Xie X; Ma YT; Fu ZY; Yang YN; Wang YH; Chen BD; Liu F
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):598-603. PubMed ID: 19040046
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability.
Cipollone F; Prontera C; Pini B; Marini M; Fazia M; De Cesare D; Iezzi A; Ucchino S; Boccoli G; Saba V; Chiarelli F; Cuccurullo F; Mezzetti A
Circulation; 2001 Aug; 104(8):921-7. PubMed ID: 11514380
[TBL] [Abstract][Full Text] [Related]
4. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.
Liu PY; Chen JH; Li YH; Wu HL; Shi GY
Thromb Haemost; 2003 Jul; 90(1):132-9. PubMed ID: 12876636
[TBL] [Abstract][Full Text] [Related]
6. Cyclo-oxygenase-2 -765G > C promoter variants are associated with lower carotid plaque echogenicity in Japanese.
Furukado S; Sakaguchi M; Yamagami H; Yagita Y; Hoshi T; Abe Y; Hougaku H; Hori M; Sakoda S; Kitagawa K
Cerebrovasc Dis; 2009; 27(1):91-8. PubMed ID: 19033684
[TBL] [Abstract][Full Text] [Related]
7. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma.
Szczeklik W; Sanak M; Szczeklik A
J Allergy Clin Immunol; 2004 Aug; 114(2):248-53. PubMed ID: 15316498
[TBL] [Abstract][Full Text] [Related]
8. Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population.
Wang L; Ma YT; Xie X; Yang YN; Fu ZY; Li XM; Liu F; Huang Y; Ma X; Chen BD; Yuan S; Sun MH; Peng X; Wang BZ
Clin Appl Thromb Hemost; 2012; 18(1):72-8. PubMed ID: 21733941
[TBL] [Abstract][Full Text] [Related]
9. A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population.
Shi J; Misso NL; Duffy DL; Thompson PJ; Kedda MA
Clin Exp Allergy; 2004 Nov; 34(11):1714-8. PubMed ID: 15544595
[TBL] [Abstract][Full Text] [Related]
10. The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.
Skarke C; Reus M; Schmidt R; Grundei I; Schuss P; Geisslinger G; Lötsch J
Clin Pharmacol Ther; 2006 Dec; 80(6):621-32. PubMed ID: 17178263
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
Cipollone F; Fazia M; Iezzi A; Pini B; Cuccurullo C; Zucchelli M; de Cesare D; Ucchino S; Spigonardo F; De Luca M; Muraro R; Bei R; Bucci M; Cuccurullo F; Mezzetti A
Circulation; 2004 Mar; 109(12):1482-8. PubMed ID: 15037537
[TBL] [Abstract][Full Text] [Related]
12. Functional rs20417 SNP (-765G>C) of cyclooxygenase-2 gene does not predict the risk of recurrence of ischemic events in coronary patients: results of a 7-year prospective study.
Montali A; Barillà F; Tanzilli G; Vestri A; Fraioli A; Gaudio C; Martino F; Mezzetti A; Cipollone F; Arca M
Cardiology; 2010; 115(3):236-42. PubMed ID: 20299798
[TBL] [Abstract][Full Text] [Related]
13. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
14. Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction.
Xie X; Ma YT; Fu ZY; Yang YN; Ma X; Chen BD; Wang YH; Liu F
Clin Chem Lab Med; 2009; 47(3):347-52. PubMed ID: 19327107
[TBL] [Abstract][Full Text] [Related]
15. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
[TBL] [Abstract][Full Text] [Related]
16. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
[TBL] [Abstract][Full Text] [Related]
17. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.
Papafili A; Hill MR; Brull DJ; McAnulty RJ; Marshall RP; Humphries SE; Laurent GJ
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1631-6. PubMed ID: 12377741
[TBL] [Abstract][Full Text] [Related]
18. Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins.
Núñez O; Fernández-Martínez A; Majano PL; Apolinario A; Gómez-Gonzalo M; Benedicto I; López-Cabrera M; Boscá L; Clemente G; García-Monzón C; Martín-Sanz P
Gut; 2004 Nov; 53(11):1665-72. PubMed ID: 15479690
[TBL] [Abstract][Full Text] [Related]
19. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.
Cipollone F; Iezzi A; Fazia M; Zucchelli M; Pini B; Cuccurullo C; De Cesare D; De Blasis G; Muraro R; Bei R; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A
Circulation; 2003 Sep; 108(9):1070-7. PubMed ID: 12912808
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions.
Hong BK; Kwon HM; Lee BK; Kim D; Kim IJ; Kang SM; Jang Y; Cho SH; Kim HK; Jang BC; Cho SY; Kim HS; Kim MS; Kwon HC; Lee N
Yonsei Med J; 2000 Feb; 41(1):82-8. PubMed ID: 10731924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
